Skip to main content

Advertisement

SpringerLink
Log in

Patients with porphyria bask in sunlight of FDA approval

  • News
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

The US regulator’s go-ahead is a boon for people with a rare form of porphyria that results in painful photosensitivity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Tequesta, FL, USA

    Mark Ratner

Authors
  1. Mark Ratner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ratner, M. Patients with porphyria bask in sunlight of FDA approval. Nat Biotechnol 37, 1390–1391 (2019). https://doi.org/10.1038/s41587-019-0347-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41587-019-0347-0

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation